NDC 78206-142-99 - MAXALT
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 78206-142
- Requested NDC
- 78206-142-99
- Package NDCs from labels
- 78206-142-99, 78206-142-01
- Manufacturer
- Organon LLC
- Effective date
- 2026-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MAXALT - Organon LLC | Organon LLC | 2026-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 78206-142-01 | MAXALT | 18 in 1 CARTON | TABLET | 18 | 4 | |
| 78206-142-99 | MAXALT | 1 in 1 POUCH | TABLET | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 78206-142 | MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [ORGANON LLC] | 2 | Current NDC, Legacy NDC, 2 package rows | 20220623_007b4644-e0e7-4863-9ae3-fe09676b3f5f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 78206-142-01 | EA - Each | 78206-142 | 978bec7f-e80c-4dd3-8d46-921323802be7 | 1 | 2021-10-08 |
| 78206-142-99 | EA - Each | 78206-142 | ee229221-b2c8-4c8a-a62e-dddd330a38b5 | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | 4a5b43f6-a5ea-4d6f-941f-3c19f242c896 | 2022-05-01 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Cipla USA Inc. | f462a507-921c-41c2-93ba-36003b6e8914 | 2022-01-13 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| CLINIMIX E | LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE | Baxter Healthcare Company | 8469d6fb-d6ef-476f-8cc3-0905192de0a8 | 2021-04-13 | Warnings, Adverse reactions | TE7660XO1C |
| CLINIMIX | LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DEXTROSE | Baxter Healthcare Corporation | dccff103-8695-400c-a15d-cc2fd078760a | 2021-04-13 | Warnings, Adverse reactions | TE7660XO1C |
| Glycine | GLYCINE | B. Braun Medical Inc. | f4d83550-42de-44c7-b8d5-1d0debc6aec2 | 2021-04-01 | Warnings, Adverse reactions | TE7660XO1C |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | Bionpharma Inc., | 91e160d6-f23f-e5e0-baec-908b2d25ce3c | 2021-03-02 | Warnings, Adverse reactions | 312837 WR978S7QHH |
| Travasol | LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE | Baxter Healthcare Corporation | 8543b5be-0f43-4891-9e56-d7c39fe839b5 | 2020-10-07 | Warnings, Adverse reactions | TE7660XO1C |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Unichem Pharmaceuticals (USA), Inc. | 3cdeccf6-36dd-4a9e-9687-2f7cce47af5f | 2020-04-08 | Warnings, Adverse reactions | 312837 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | f5520526-1cc5-489f-b142-92f92fec77d3 | 2020-02-01 | Warnings, Adverse reactions | 312837 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Teva Pharmaceuticals USA, Inc. | 4ef60c83-ba48-4134-968b-13800ea9b7f2 | 2019-10-01 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| Additox | TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | BioActive Nutritional, Inc. | 319ee2fe-58e3-495e-bf0d-df201f6fbb1c | 2018-07-18 | Warnings | Z0H242BBR1 |
| Glycine | GLYCINE | Baxter Healthcare Corporation | d4665408-04d8-4ad7-8589-708d4defb869 | 2018-01-02 | Warnings, Adverse reactions | TE7660XO1C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.